• Login
    View Item 
    •   UMB Digital Archive
    • School, Graduate
    • Theses and Dissertations All Schools
    • View Item
    •   UMB Digital Archive
    • School, Graduate
    • Theses and Dissertations All Schools
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of UMB Digital ArchiveCommunitiesPublication DateAuthorsTitlesSubjectsThis CollectionPublication DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Statistics

    Display statistics

    Multi-mechanistic inhibitors of androgen action for the treatment of prostate cancer

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Find Full text
    Author
    Vasaitis, Tadas Sean
    Advisor
    Brodie, Angela
    Njar, Vincent
    Date
    2007
    Type
    dissertation
    
    Metadata
    Show full item record
    Abstract
    Prostate cancer (PC) is a major cause of mortality among males in the USA. The prominent treatment strategy for advanced cases involves inhibition of the effects of androgens through orchidectomy, LHRH agonists/antagonists, anti-androgens, and inhibitors of androgen synthesis. Despite these treatments, nearly all patients will experience recurrence, in which they fail to satisfactorily respond to endocrine-based treatments. However, recent evidence increasingly implicates a continued role of the androgen receptor (AR), in all disease stages. Therefore, improved strategies for targeting the AR signaling axis are needed. On this basis, we are developing novel agents with the ability to block multiple targets within the androgen signaling pathway. The major targets are androgen biosynthesis, ligand-AR binding, and AR expression. The rationally designed compounds VN/125-1, VN/124-1, VN/85-1, VN/87-1, VN/108-1 and VNLG/82-1 were evaluated for inhibition of CYP17 (a key enzyme in androgen biosynthesis), and compared with the clinically used ketoconazole. For these studies, we utilized our cell-based radiometric acetic acid releasing assay. Among the effective compounds, IC50 values ranged from 0.5 to 112 nM. In competitive binding and transactivation studies, VN/124-1, VN/125-1, and VN/85-1 prevented binding of radiolabeled ligand to both the mutant LNCaP AR and the wild-type AR, and reduced AR mediated transactivation by 90-99% at 10 muM. In proliferation studies, VN/124-1, VN/125-1 and VN/85-1 inhibited the growth of DHT-stimulated LNCaP and LAPC4 cells with IC50 values in the low micromolar range (i.e., <10 muM). They also inhibited AR-negative PC3 cell proliferation, suggesting mechanisms additional to modulation of androgen signaling. Through western blot technique and immunofluorescence microscopy, the effects of VN/124-1 on AR expression and translocation were observed. VN/124-1 dramatically down-regulated AR expression, both in vitro and in vivo, which corresponded to its superior anti-tumor activity previously observed in our LAPC4 xenograft model. VN/124-1 also induced apoptosis in LNCaP cells as shown by annexin/FITC staining and caspase 3/7 activity assays. These finding suggest that combined inhibition of androgen biosynthesis, AR-mediated transactivation, and AR expression represents a new class of agents with exciting potential for PC treatment.
    Description
    University of Maryland, Baltimore. Pharmacology and Experimental Therapeutics. Ph.D. 2007
    Keyword
    Health Sciences, Pharmacology
    Health Sciences, Oncology
    Identifier to cite or link to this item
    http://hdl.handle.net/10713/1016
    Collections
    Theses and Dissertations School of Medicine
    Theses and Dissertations All Schools

    entitlement

     
    DSpace software (copyright © 2002 - 2022)  DuraSpace
    Quick Guide | Policies | Contact Us | UMB Health Sciences & Human Services Library
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.